181. Bioaccess with Julio Martinez-Clark
Update: 2025-08-22
Description
Medical innovation is often hindered by the high costs of clinical trials and the complexity of navigating government regulations and reporting requirements. For many companies, this prevents life-saving advances from reaching the market. Now, there is a way to accelerate human clinical trials and reduce development expenses. This represents one of the positive aspects of globalization. Julio Martinez-Clark, CEO of Bioaccess, is here today.
Key Takeaways To Tune In For:
Resources talked about in this episode:
Website:
Podcast: Global Trial Accelerators
Social media handles: LinkedIn
Comments
In Channel



